Opinions
The Panic-Proof Portfolio (Stockchase Research)
City Office REIT, Inc.
CIO-N
TOP PICK
Dec 17, 2020
$9.710
Stock price when the opinion was issued
REAL ESTATE
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick Dec 17/20, Up 23.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CIO has achieved its $12 objective. To be disciplined, we recommend covering 50% at this level and trailing up the stop from $7.00 to $10.50. It triggered, this would result in a combined return on investment over 15%.
REAL ESTATE
PAST TOP PICK
(A Top Pick Dec 17/20, Up 71.7%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with JEF is progressing well. We recommend trailing up the stop (from $10.50) to $14.50. If triggered, this would result in a net investment return of 36%, considering the previous recommendation to cover half the position.
REAL ESTATE
PAST TOP PICK
(A Top Pick Dec 17/20, Up 90.9%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CIO is progressing well. We now recommend trailing the stop (from $14.50) to $16.50. If triggered, this would all but guarantee a net investment return of 46%, considering our recommendation to previously cover half the position.
REAL ESTATE
PAST TOP PICK
(A Top Pick Dec 17/20, Up 69.9%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CIO has triggered its stop at $16.50. To remain disciplined, we recommend covering the position at this time. This will result in a net investment gain of 46% when combined with the previous recommendation to cover half the position.
REAL ESTATE
Stockchase Research Editor: Michael O'Reilly CIO is a REIT that holds 5.8 million square feet of rentable area office space mostly in the US southern and western states. Recent earnings of $0.35 per share beat expectations by over 12% and compares to $0.29 a year ago. Holding office property has obviously been a roller coaster during the pandemic; however, with vaccines coming forward, the hope is the worst may be over. It has a great yield backed by a 51% payout ratio. We would buy this with a $7 stop-loss, looking to achieve $12 -- over 24% upside. Yield 6.16% (Analysts’ price target is $12.00)